Clinical Study

Azilsartan as “Add-On” Treatment with Methotrexate Improves the Disease Activity of Rheumatoid Arthritis

Table 5

Effect of azilsartan (Azil) on serum lipid profile of patients with active RA maintained on methotrexate (MTX).

ParametersMTX + placebo MTX + Azil
BaselineAfter 90 daysBaselineAfter 90 days

Triglycerides (mg/dl)
Cholesterol (mg/dl)
LDL-c (mg/dl)
HDL-c (mg/dl)

Values are presented as mean ± S.D; : number of patients; different compared with baseline within the same group ; values with different superscripts (a, b) within each parameter are significantly different . LDL-c: low-density lipoprotein cholesterol; HDL-c: high-density lipoprotein cholesterol.